• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

MIT researchers think microparticles could deliver ‘self-boosting’ vaccines

July 19, 2022 By Sean Whooley

MIT Self Boosting Vaccine
[Image from Second Bay Studios, edited by MIT News]
MIT researchers are touting microparticles that can deliver payloads at different points, potentially creating “self-boosting” vaccines.

A new study, highlighted on the institute’s news website, demonstrates a way in which researchers could design vaccines that would need to be given just once before they “self-boost,” or essentially re-deliver the therapeutic, at a specified point in the future. The particles can remain under the skin until the vaccine is released, then break down like resorbable sutures.

Such vaccine delivery could be useful for childhood vaccinations in regions where people don’t have frequent access to medical care, according to the researchers.

“This is a platform that can be broadly applicable to all types of vaccines, including recombinant protein-based vaccines, DNA-based vaccines, even RNA-based vaccines,” Ana Jaklenec, a research scientist at MIT’s Koch Institute for Integrative Cancer Research, said on the MIT website. “Understanding the process of how the vaccines are released, which is what we described in this paper, has allowed us to work on formulations that address some of the instability that could be induced over time.”

Jaklenec and Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, are the senior authors of the new study, which was published in Science Advances. Morteza Sarmadi, a research specialist at the Koch Institute and recent MIT PhD recipient, was the lead author of the paper.

The researchers also say the method could be used to deliver other therapeutics, like cancer drugs, hormone therapy and biologic drugs.

Resembling tiny coffee cups, the particles were formed through the creation of arrays of silicon molds used to shape PLGA (a biocompatible polymer that has already been approved for use in medical devices such as implants, sutures, and prosthetic devices) cups and lids. The researchers then placed a custom-built, automated dispensing system to fill each cup with a drug or vaccine, after which point the lids are aligned and lowered on the cups and the system is heated slightly until the cup and lid fuse together to seal the drug inside.

The method, called SEAL (StampEd Assembly of polymer Layers), can be used to produce particles of any shape or size, the researchers say. They found that the particles can release their payload at different times based on the differences in composition of the polymer and chemical groups attached at the ends of the polymers.

“If you want the particle to release after six months for a certain application, we use the corresponding polymer, or if we want it to release after two days, we use another polymer,” Sarmadi said. “A broad range of applications can benefit from this observation.”

The research was funded by the Bill and Melinda Gates Foundation.

Filed Under: Drug-Device Combinations, Nanoparticles, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology, mit

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS